IDiyas

For the Inventor, By the Inventor

Englishtown, NJ, United States of America

Raymond F White

USPTO Granted Patents = 19

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 118(Granted Patents)


Location History:

  • Englishtown, NJ (US) (1987 - 1994)
  • Palmyia, VA (US) (1994 - 1995)

Company Filing History:

goldMedal19 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1987-1995

Loading Chart...
19 patents (USPTO):Explore Patents
1. 5468771 - Cholesterol lowering compound (1995-11-21),
2. 5318901 - Method for the production of a modified '8-amino acid' cyclosporin (1994-06-07),
3. 5302604 - Cholesterol lowering compounds produced by directed biosynthesis (1994-04-12),
4. 5294627 - Directed biosynthesis of biologically active compounds (1994-03-15),
5. 5273979 - C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent (1993-12-28),
6. 5270332 - Cholesteral lowering agents (1993-12-14),
7. 5250422 - Biotransformation process for the production of invermectin derivatives (1993-10-05),
8. 5225338 - Microbial preparation of 13.beta.-13-deoxy-22,23-dihydro (1993-07-06),
9. 5221625 - Cyclcic FR-900520 microbial biotransformation agent (1993-06-22),
10. 5218125 - Antihypertensive compound and method of use thereas (1993-06-08),
11. 5214153 - Actinoplanes transformation process anti-hypertensive compound and (1993-05-25),
12. 5202309 - Antibiotic cyclopeptide fermentation product (1993-04-13),
13. 5194377 - Antibiotic agent (1993-03-16),
14. 5087702 - Microbial transformation process for producing an antihypertensive (1992-02-11),
15. 5070015 - Novel avermectins are produced from known microorganisms (1991-12-03),

Title: Innovations in Immunosuppression: The Contributions of Raymond F. White

Introduction

Raymond F. White, a distinguished inventor based in Englishtown, NJ, has made significant contributions to the field of pharmaceuticals, amassing an impressive portfolio of 19 patents. His work primarily focuses on groundbreaking innovations that address critical health issues, particularly in immunosuppression therapies.

Latest Patents

Among his latest patents, Raymond F. White has developed a cholesterol-lowering compound and a method for producing a modified '8-amino acid' cyclosporin. This cyclosporin derivative, which incorporates '8-(3-fluoro-D-alanine)' or '8-(2-deutero-3-fluoro-D-alanine)', is isolated from the fermentation broth of incubating Tolypocladium inflatum MF5080 (NRRL 8044) with the respective compounds. These modified cyclosporins exhibit notable immunosuppressive properties, showcasing White's innovative approach towards addressing complex medical challenges.

Career Highlights

Raymond F. White is currently associated with Merck & Company, Inc., a leading global healthcare company. His role at Merck emphasizes the importance of innovation in developing new therapeutic compounds, underscoring his commitment to advancing medical science and improving patient outcomes.

Collaborations

Throughout his career, Raymond has collaborated with esteemed colleagues such as Shieh-Shung T. Chen and Byron H. Arison. These collaborations reflect a shared dedication to innovation and the pursuit of excellence within the pharmaceutical industry, contributed by valuable insights and expertise from all involved.

Conclusion

Raymond F. White's contributions to pharmacology, particularly in the realm of immunosuppression, reinforce the critical role of inventors in advancing medical technology. With a robust patent portfolio and ongoing collaborations, White continues to pave the way for future innovations that will significantly impact healthcare. His work serves as an inspiration for aspiring inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…